Alphatec Holdings, Inc. (ATEC) Stock Price & Analysis

Alphatec Holdings, Inc. (ATEC) closed at USD 11.36 on Thursday, October 22, 2026, up 4.60% on the day. The US market is currently closed (pre-market); this is not a live price.

The prior close was USD 10.86; the Oct 22, 2026 session ranged USD 10.9–11.6 on volume of 3,180,368 shares. Market capitalization is $1.75B, with a 52-week range of USD 6.82–23.29 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.

Also available as compact Markdown for AI agents: nexqual.com/ATEC.md

Key facts (ATEC)

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ATEC)

USDFY2021FY2022FY2023FY2024FY2025TTM
Revenue$243M$351M$482M$612M$764M$815M
Gross profit$158M$233M$310M$424M$532M—
Operating income-$128M-$147M-$173M-$136M-$82.1M-$49.2M
Net income-$143M-$151M-$187M-$162M-$143M-$110M
EPS (diluted)-$1.49-$1.46-$1.54-$1.13-$0.96—
Free cash flow-$142M-$125M-$159M-$128M$2.8M$2.3M
Gross margin64.9%66.4%64.3%69.4%69.6%—
Operating margin-52.7%-41.9%-36.0%-22.3%-10.7%-6.0%
Net margin-58.8%-43.1%-38.7%-26.5%-18.8%-13.5%
Revenue growth+67.9%+44.3%+37.4%+26.8%+25.0%—
Cash + short-term investments$187M$84.7M$221M$139M$161M—
Total debt$327M$364M$513M$576M$566M—

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (ATEC)

P/S 2.1x · EV/EBITDA 115.8x · EV/Sales 2.7x · P/FCF 760.5x · FCF yield 0.13% · Earnings yield -6.27% · Net debt $457M · EV $2.21B

Superinvestors (SEC 13F-HR, Q2 2026) (ATEC)

1 of 80 tracked investors hold ATEC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

InvestorFirm% of portfolioValueChange
First Eagle InvestmentFirst Eagle Investment Management0.01%$8.6MAdded +43.1%

Analysts (ATEC)

Consensus Buy (mean 1.79 on a 1–5 scale), 14 analysts; mean target USD 15.79 (low 12, high 24).

Rating changes, last 120 days:

DateFirmActionRatingPrice target
2026-08-05UBSTarget raisedBuy$15 → $16
2026-08-05TD CowenTarget raisedBuy$11 → $13
2026-08-05BMO CapitalTarget raisedOutperform$11 → $12
2026-07-28UBSInitiatedBuy$15
2026-07-23Stephens & Co.InitiatedOverweight$15
2026-07-09BMO CapitalInitiatedOutperform$11
2026-07-08StifelTarget loweredBuy$16 → $13

Total return (dividends reinvested) (ATEC)

1Y (from 2025-10-23)5Y (from 2021-10-18)
Total return-28.5%-6.6%
S&P 500 (SPY)+14.9%+80.3%
Per year-28.6%-1.4%
Volatility (annualized)72.8%65.0%
Max drawdown-69.2% (Jan 2026→May 2026)-72.1% (Jul 2023→Oct 2024)

ATEC analyst estimates and revisions

PeriodEPS estimate90 days agoChangeRevenue estimateAnalysts
Current quarter (ends Sep 2026)$0.09$0.09+0.9%$225.1M9
Next quarter (ends Dec 2026)$0.15$0.15+2.9%$251.5M9
Current fiscal year (ends Dec 2026)$0.33$0.32+2.9%$882.1M10
Next fiscal year (ends Dec 2027)$0.60$0.58+3.7%$1.02B10

Key Statistics (as of October 23, 2026 at 09:25 UTC)

PriceUSD 11.36
Change▲ 4.60% (up)
Previous CloseUSD 10.86
OpenUSD 10.9
Day RangeUSD 10.9 – 11.6
52-Week RangeUSD 6.82 – 23.29
Volume3,180,368 shares
Market Cap$1.75B
ExchangeNMS

Technical Analysis (ATEC)

Nexqual's technical model rates ATEC "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.

Overall SignalBUY
RSI (14)61.98 (neutral)
vs SMA50Above (USD 10.04)
MACD0.26 (positive)

Analyst Ratings (ATEC)

Wall Street analysts rate ATEC "Buy" based on 14 analysts, with a mean price target of USD 15.79 (range USD 12–24), per Nexqual as of October 23, 2026 at 09:25 UTC.

Consensus RatingBuy
Analyst Count14
Mean TargetUSD 15.79
High TargetUSD 24
Low TargetUSD 12
Buy / Hold / Sell14 / 0 / 0

Earnings (ATEC)

Next Earnings Date2026-10-29
EPS EstimateUSD 0.09
Revenue Estimate$225.14M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD 0.07 vs est 0.07 ▲ beat
2026-03-31USD 0 vs est -0 ▲ beat
2025-12-31USD 0.06 vs est 0.04 ▲ beat
2025-09-30USD 0.03 vs est -0.02 ▲ beat

Source: Nexqual, October 23, 2026 at 09:25 UTC.

Financials & Fundamentals (ATEC)

Total Revenue$815.05M
Revenue Growth (latest quarter, YoY)+15.10%
Gross Margin+70.84%
Operating Margin-0.93%
Profit Margin-13.49%
ROE-373.44%
Debt / Equity52.37
Current Ratio1.89
Total Cash$118.66M
Total Debt$604.02M
Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K)$2.31M (0.3% of revenue)

Source: Nexqual, October 23, 2026 at 09:25 UTC.

Financial Health Score (ATEC)

Nexqual rates Alphatec Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.

GrowthStrong — Revenue +25% YoY (annual)
ProfitabilitySolid — Gross margin 71%, operating -1% (last 12 months)
Balance SheetCritical — $119M cash and investments vs $576M debt (Jun 2026, SEC)
Cash FlowMixed — FCF $2M (last 4 quarters to Jun 2026, SEC), slim 0.3% margin
EfficiencyCritical — ROE -373%, ROA -3.1%

Ownership (ATEC)

Insider Ownership+20.59%
Institutional Ownership+75.81%
Shares Outstanding154.45M
Float122.06M
Short % of Float+10.52%

Source: Nexqual, October 23, 2026 at 09:25 UTC.

Leadership (ATEC)

Alphatec Holdings, Inc. is led by Patrick S. Miles, Chairman, CEO & President, per Nexqual as of October 23, 2026 at 09:25 UTC.

Chairman, CEO & PresidentPatrick S. Miles
Executive VP & CFOJ. Todd Koning
Chief Operating OfficerScott Lish
Executive Vice President of SalesDavid P. Sponsel
Executive Vice President of People & CultureCraig E. Hunsaker

Major Backers & Investors (ATEC)

Notable institutional backers of Alphatec Holdings, Inc. include Braidwell LP , American Century Companies Inc, BNP Paribas Asset Management Holding S.A., according to Nexqual as of October 23, 2026 at 09:25 UTC.

Active Investors

InvestorStake
Braidwell LP 4.23%
American Century Companies Inc4.22%
BNP Paribas Asset Management Holding S.A.2.29%
Jacobs Levy Equity Management, Inc.2.17%
Royal Bank of Canada1.94%

Index Funds (Passive)

FundStake
BlackRock7.33%
Vanguard Group3.32%
State Street2.25%
Geode Capital2.06%
Nuveen1.68%

Source: Nexqual, October 23, 2026 at 09:25 UTC.

Peers & Related Stocks

SymbolNamePriceChange
BFLYButterfly Network, Inc.USD 6.81▼ 4.08%
ESTAEstablishment Labs Holdings IncUSD 63.52▲ 1.99%
ALMRAlamar Biosciences, Inc.USD 29.72▼ 5.5%
INSPInspire Medical Systems, Inc.USD 72.66▲ 2.24%
AXGNAxoGen, Inc.USD 36.68▲ 0.55%
UFPTUFP Technologies, Inc.USD 297.33▲ 2.49%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt